Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
hla-a2 restricted glioma antigen peptides vaccine (1 trial)
poly-iclc (1 trial)
Trials (1 total)
Trial APIs (2 total)